These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 6142671

  • 1. Desensitization for sulfasalazine skin rash.
    Purdy BH, Philips DM, Summers RW.
    Ann Intern Med; 1984 Apr; 100(4):512-4. PubMed ID: 6142671
    [Abstract] [Full Text] [Related]

  • 2. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
    Akahoshi K, Chijiiwa Y, Kabemura T, Okabe H, Akamine Y, Nawata H.
    J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
    [Abstract] [Full Text] [Related]

  • 3. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI, Present DH, Rubin PH, Fochios SE.
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sulfasalazine pneumonitis.
    Averbuch M, Halpern Z, Hallak A, Topilsky M, Levo Y.
    Am J Gastroenterol; 1985 May; 80(5):343-5. PubMed ID: 2859799
    [Abstract] [Full Text] [Related]

  • 6. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE, Amos RS.
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [Abstract] [Full Text] [Related]

  • 7. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V.
    Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R.
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract] [Full Text] [Related]

  • 13. Pulmonary infiltrates and skin pigmentation associated with sulfasalazine.
    Gabazza EC, Taguchi O, Yamakami T, Machishi M, Ibata H, Suzuki S, Matsumoto K, Kitagawa T, Yamamoto J.
    Am J Gastroenterol; 1992 Nov; 87(11):1654-7. PubMed ID: 1359782
    [Abstract] [Full Text] [Related]

  • 14. Desensitization to sulphasalazine in patients with arthritis.
    Koski JM.
    Clin Exp Rheumatol; 1993 Nov; 11(2):169-70. PubMed ID: 8099541
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.
    Yamakado S, Yoshida Y, Yamada T, Kishida T, Kobayashi M, Nomura T.
    Intern Med; 1992 Jan; 31(1):108-13. PubMed ID: 1348965
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
    Sullivan SN.
    J Clin Gastroenterol; 1987 Aug; 9(4):461-3. PubMed ID: 2888803
    [Abstract] [Full Text] [Related]

  • 19. Pancreatitis and pancreatic necrosis during sulfasalazine therapy.
    Faintuch J, Mott CB, Machado MC.
    Int Surg; 1985 Aug; 70(3):271-2. PubMed ID: 2872181
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.